Mianserin versus lorazepam, each with escitalopram, for depression with sleep problems
About this title
Read the official source — NCT05599126This study evaluates the effectiveness of Mianserin for people with depression.
Understand this study
What is this study about?
This study evaluates the effectiveness of Mianserin for people with depression.
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
- Listed locations
- ShanghaiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 300
- Sponsor
- Zhenghui YI
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT05599126
- Official title
Show the full official title
A Multicenter Open Study of the Efficacy of Mianserin in Combination With SSRIs in Patients With Depression With Sleep Problems
Recruitment & locations
Shanghai
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the effectiveness of Mianserin for people with depression.
Who is behind this study?
The study sponsor is Zhenghui YI.
Does this study involve medication?
Yes. The study involves medication, including Mianserin and Lorazepam.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria apply.
